Unit: 1 Box (20 Tests)
Regulatory Status: CLIA Waived (Nasal Swab) / Moderately Complex (Nasal Wash / Nasal Aspirate) / Professional Use Only
Contents: (20) Test Strip, (1) Reagent Solution, (20) Extraction Tube, (20) Disposable Droppers, (20) Nasopharyngeal Swab, (1) Positive RSV Control Swab, (1) Negative Control Swab. (1) Package Insert, (1) Quick Reference Instructions
Determinations: Qualitative Respiratory Syncytial Virus (RSV)
Storage Requirements: 59° – 86° F
Processing Time: 15 Minutes
The QuickVue RSV Test is a convenient, on-site dipstick immunoassay that offers a qualitative detection of the respiratory syncytial virus (RSV) in 15 minutes or less. RSV is the most common cause of bronchiolitis and pneumonia in children under the age of one in the U.S. The RSV infection begins in the upper respiratory epithelium, quickly progressing downward and causing inflammation, fluid collection, and obstruction in the bronchioles and alveoli, leading to serious respiratory distress. Each year, over 75,000 children are hospitalized due to complications from RSV infection. RSV testing can be a valuable diagnostic tool, allowing parents and doctors to begin supportive care at earlier stages, lessening the severity of the illness and potential for life-threatening complications.
QuickVue RSV Test Includes:
20 Individually packaged Test Strips
20 Extraction Tubes
20 Disposable Droppers
20 Sterile Nasopharyngeal swabs
1 Extraction Reagent Bottle
1 Positive RSV Control swab
1 Negative Control Swab
1 Package Insert
1 Procedure Card
- Fast – Results in 15 minutes or less.
- Convenient – The QuickVue RSV Test can be used in conjunction with the QuickVue Influenza Test to obtain 2 results with a single specimen sample.
- Easy-to Read – Two-color endpoint qualitative results
- Accurate – Nasopharyngeal aspirate: 99% Sensitivity, Nasopharyngeal Swab: 92% Sensitivity, and Nasal/Nasopharyngeal Wash: 83% Sensitivity
- Dependable Performance – Includes both Internal & External Controls to insure compliance and confidence in results
- Long Shelf Life – 24 months from date of manufacture
- No special storage or shipping required – Stable at Room Temperature (59-86 degrees F)
- CLIA Waived
The RSV virus is an enveloped, non-segmented, negative-sense RNA virus classified in the subfamily Pneumovirinae of the Paramyxoviridae family. Virus replication begins in the nasopharynx, then replicates principally in the superficial layer of the respiratory epithelium and then spreads downward into the lower respiratory tract through the inhalation of secretions. This causes inflammation of the bronchioles resulting in wheezing, difficulty breathing, and sometimes respiratory failure.
Respiratory syncytial virus is spread easily through inhalation of virus-laden aerosolized particles (produced by normal breathing, speaking, singing, coughing, or sneezing ), direct contact with infected individuals, or contact with contaminated objects. The virus can linger on surfaces for up to eight hours and can be contagious for up to 8 days. Infections normally occur in the US between November and April. Infection can occur at all ages, but can be more critical in premature infants; children with chronic lung disease, congenital heart disease, or immune system deficiencies; and adults over the age of 65.
The typical RSV infection causes mild, cold-like symptoms in adults and healthy school-aged children. Symptoms tend to appear 4-6 days after exposure and include a coughing, sneezing, stuffy and/or runny nose, fever, and a decreased appetite. These symptoms normally diminish in 7 to 14 days, but the cough may linger for weeks. Complications with RSV that can occur in higher risk patients include croup, ear infections, and pneumonia. There is no treatment option for RSV viral infections. Mild infections resolve on their own. However, supportive care can be used in the form of bronchiodilators (to keep airways open), humidifiers, and over-the-counter medications to relieve symptoms.
For more severe cases and high-risk patients, doctors may prescribe an antiviral medication. Antiviral medications can be used to effectively reduce the intensity and duration of symptoms, but they cannot treat or prevent infection of RSV. These medications work best if the patient begins taking them at early on-set of symptoms. The QuickVue RSV Test combines testing, diagnosis, and symptom management all in the same doctor’s visit, which could reduce the potential for serious complications.